Pfizer investors stand with CEO Read even though he is 0 for 2 on megamergers

Eric Palmer Pfizer CEO Ian Read walked away from its $ 160 billion merger with Allergan this week after U.S. Treasury Department rule changes sucked the value out of its tax inversion ...

Glaxo CEO: Consumer health can stand on its own, but don’t expect a quick spinoff

Carly Helfand Lately, GlaxoSmithKline CEO Andrew Witty has seemed open to splitting off the industry-leading consumer health joint venture he formed with Novartis last year. But let ...
© 2017 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS